GENE ONLINE|News &
Opinion
Blog

Deals
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
Cytena Bioprocess Solutions Closes Pre-A series Funding, Accelerates Development in Microbioreactors
2020-12-29Partner
Putting the Bio in Canadian Biomanufacturing
2020-12-25
China’s Hasten Biopharmaceutic Acquires Five Non-Core Assets from Japan’s Takeda
2020-12-24
M&A
Servier Aims to Expand Portfolio for Hematological Cancers by Acquiring Agios
2020-12-23
Novartis Looks to Diversify Neuroscience Pipeline with $770 Million Worth Acquisition
2020-12-22
Ginkgo Acquires Bioengineering Assets of Massachusetts-Based Biotech Startup
2020-12-20
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
Neuron23 Emerges from Stealth with $113.5 Million Financing
2020-12-18
Japan’s AnGes Acquires EmendoBio, Eying High Precision Gene-Editing Technology
2020-12-17
Why is Eli Lilly Seeking Prevail’s Gene Therapy Pipeline?
2020-12-17
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
Orladeyo’s FDA approval Heralds New Funding for BioCryst
2020-12-13
SK Holdings Supports Roivant’s New Protein Degradation Platform with US$ 200 Million Investment
2020-12-13
Hoping to Boost Revenue Growth, Gilead Acquires MYR in a $1.4 B Deal
2020-12-13
1 37 38 39 40 41 47
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top